111.48 - 114.40
76.75 - 114.39
5.09M / 4.21M (Avg.)
23.96 | 4.77
Analyze DCF forecasts for the company and compare them with competitors.
39.42B
Revenue has increased from the previous period.
8.68%
Revenue growth rate has increased from the previous period.
6.21B
EBITDA has decreased from the previous period.
15.75%
EBITDA margin has decreased from the previous period.
4.02B
EBIT has decreased from the previous period.
10.19%
EBIT margin has decreased from the previous period.
2.19B
Depreciation has increased from the previous period.
9.32B
Total cash has increased from the previous period.
23.64%
Cash percentage has increased from the previous period.
3.06B
Receivables have decreased from the previous period.
7.75%
Receivables percentage has decreased from the previous period.
4.65B
Inventories have increased from the previous period.
11.80%
Inventory percentage has decreased from the previous period.
3.24B
Accounts payable has decreased from the previous period.
8.23%
Payables percentage has decreased from the previous period.
-1.84B
Capital expenditure has decreased from the previous period.
-4.66%
CapEx percentage has decreased from the previous period.
9.65%
WACC has decreased from the previous period.
10.90%
Cost of equity is unchanged from the previous period.
4.40%
Cost of debt is unchanged from the previous period.
1.38
Beta is unchanged from the previous period.
729.20M
Diluted shares outstanding is unchanged from the previous period.
13.52B
Total debt is unchanged from the previous period.
68.33B
Total equity is unchanged from the previous period.
81.85B
Total capital is unchanged from the previous period.
16.51%
Debt weighting is unchanged from the previous period.
83.49%
Equity weighting is unchanged from the previous period.
3.03B
EBIAT has decreased from the previous period.
4.78B
UFCF has increased from the previous period.
2.00%
Long-term growth rate is unchanged from the previous period.
56.34B
Terminal value is unchanged from the previous period.
50.72B
Enterprise value has increased from the previous period.
6.94B
Net debt is unchanged from the previous period.
43.78B
Equity value has increased from the previous period.
60.04
Equity value per share has increased from the previous period.
Analyze analyst forecasts for the company and compare them with competitors.
38.39B
The estimated revenue has increased from the previous period.
6.05B
The estimated EBITDA has increased from the previous period.
5.53
The estimated EPS has increased from the previous period.
3.97B
The estimated net income has increased from the previous period.
3.91B
The estimated EBIT has increased from the previous period.
8.60B
The estimated SG&A expenses have increased from the previous period.
View analysts' price targets and recommendations, and compare them with competitors.
$114.00
Analysts expect the stock price to decrease by 0.24%.
Buy
Positive consensus among analysts.
